Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
RLAY holding history
Relay Therapeutics, Inc. in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −2,117,646−100.0% | Sold out | Holders |
| Q1 2025 | 2,117,646 | $5.55M | 0.9% | −58,000−2.7% | Reduced | Holders |
| Q4 2024 | 2,175,646 | $8.96M | 1.0% | +549,500+33.8% | Added | Holders |
| Q3 2024 | 1,626,146 | $11.5M | 1.4% | +20,800+1.3% | Added | Holders |
| Q2 2024 | 1,605,346 | $10.5M | 3.0% | +115,176+7.7% | Added | Holders |
| Q1 2024 | 1,490,170 | $12.4M | 3.2% | +172,300+13.1% | Added | Holders |
| Q4 2023 | 1,317,870 | $14.5M | 5.0% | +447,000+51.3% | Added | Holders |
| Q3 2023 | 870,870 | $7.32M | 3.6% | +169,300+24.1% | Added | Holders |
| Q2 2023 | 701,570 | $8.81M | 3.0% | −144,700−17.1% | Reduced | Holders |
| Q1 2023 | 846,270 | $13.9M | 5.3% | +131,422+18.4% | Added | Holders |
| Q4 2022 | 714,848 | $10.7M | 3.5% | +714,848 | New | Holders |